CHICAGO, Dec. 19, 2023 /PRNewswire/ — The Defense Cybersecurity Market is estimated to be USD 36.9 billion in 2023 and is projected to reach USD 49.4 billion by 2028, at a CAGR of 6.0% from 2023 to 2028 according to a new report by MarketsandMarkets™. Defense cybersecurity refers to the comprehensive set of practices, technologies, and… Continue reading Defense Cybersecurity Market worth $49.4 billion by 2028 – Exclusive Report by MarketsandMarkets™
Category: Newswire
Geotab® wins Telematics Award at What Van? Awards 2024
Award recognises Geotab’s innovation in fleet management LONDON, Dec. 19, 2023 /PRNewswire/ — Geotab Inc. (“Geotab”), a global leader in connected transportation solutions, has been recognised at this year’s What Van? Awards, winning the Telematics category for its powerful telematics solutions for fleets for the second consecutive year, notably those comprising vans and Light Commercial… Continue reading Geotab® wins Telematics Award at What Van? Awards 2024
Tianjin’s Youthful Energy Sparks Citywide Revival
TIANJIN, China, Dec. 19, 2023 /PRNewswire/ — A report from China Daily: Tianjin, a city in North China, is undergoing a dynamic transformation driven by its vibrant young people. China Daily Potside Chats hosts, Nathan and Stephanie, recently explored the city’s cutting-edge developments led by the younger generation. Continue Reading The charging robot undergoes replenishment… Continue reading Tianjin’s Youthful Energy Sparks Citywide Revival
U.S. Hospital Facilities Market Analysis Report 2023-2030 – Market Projected to Surpass $2540 Billion by 2030 with Focus on Patient Service and Technology Integration
DUBLIN, Dec. 20, 2023 /PRNewswire/ — The “U.S. Hospital Facilities Market Size, Share & Trends Analysis Report by Patient Service, Facility Type (Private Hospitals, Public/Community Hospitals), Bed Size, Service Type, and Segment Forecasts, 2023-2030” report has been added to ResearchAndMarkets.com’s offering. The U.S. hospital facilities market size is anticipated to reach USD 2540.4 billion by 2030 and is… Continue reading U.S. Hospital Facilities Market Analysis Report 2023-2030 – Market Projected to Surpass $2540 Billion by 2030 with Focus on Patient Service and Technology Integration
Exro Provides Operational Update in Year-End Shareholder Letter
CALGARY, AB, Dec. 20, 2023 /PRNewswire/ – Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) (the “Company” or “Exro“), a leading clean-technology company that develops new generation power-control electronics that expand the capabilities of electric motors and batteries, today provided an operational update in a 2023 year-end letter to shareholders. Dear Exro Shareholders, As we reach the end… Continue reading Exro Provides Operational Update in Year-End Shareholder Letter
Global Super High Frequency Communication Market Analysis Report 2023-2030 – Market Poised for Significant Growth with Promising CAGR of 16.5% by 2030
DUBLIN, Dec. 20, 2023 /PRNewswire/ — The “Global Super High Frequency Communication Market Size, Share & Trends Analysis Report by Technology Type (5G sub-6 GHz, 5G mm Wave), Frequency Range, Radome Type, Region, and Segment Forecasts, 2023-2030” report has been added to ResearchAndMarkets.com’s offering. The global super high frequency communication market size is expected to reach USD… Continue reading Global Super High Frequency Communication Market Analysis Report 2023-2030 – Market Poised for Significant Growth with Promising CAGR of 16.5% by 2030
Explore AsiaRF’s Wireless Innovations at CES 2024, Las Vegas: Tech Excellence Unveiled.
TAIPEI, Dec. 20, 2023 /PRNewswire/ — AsiaRF, a global leader in wireless connectivity, is thrilled to announce its participation in CES 2024, the world’s premier tech event, held in Las Vegas from January 9th to 12th. AsiaRF is excited to showcase its latest advancements in Wi-Fi HaLow technology, powered by our strategic partner Morse Micro,… Continue reading Explore AsiaRF’s Wireless Innovations at CES 2024, Las Vegas: Tech Excellence Unveiled.
Global Amino Acids Market Size, Share & Trends Analysis Report 2024-2030 – Market to Surpass USD 48.30 Billion by 2030 with Prominent Growth in Dietary Supplements Sector
DUBLIN, Dec. 20, 2023 /PRNewswire/ — The “Global Amino Acids Market Size, Share & Trends Analysis Report by Type (Essential, Non-essential), Source (Plant-based, Animal-based), Grade (Food, Feed), End-use (Food & Beverages, Dietary Supplements), Region, and Segment Forecasts, 2024-2030” report has been added to ResearchAndMarkets.com’s offering. The global amino acids market is expected to reach USD 48.30… Continue reading Global Amino Acids Market Size, Share & Trends Analysis Report 2024-2030 – Market to Surpass USD 48.30 Billion by 2030 with Prominent Growth in Dietary Supplements Sector
Bahrain Construction Market Size, Trend Analysis and Forecast to 2027 – Delays in the Execution of Projects and a Fall in the Inflow of Foreign Direct Investment in the Construction Sector
DUBLIN , Dec. 20, 2023 /PRNewswire/ — The “Bahrain Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The projection of construction industry growth in Bahrain has been revised down to an expansion of 1.2% in 2023, compared with earlier projection of 4% growth rate. According… Continue reading Bahrain Construction Market Size, Trend Analysis and Forecast to 2027 – Delays in the Execution of Projects and a Fall in the Inflow of Foreign Direct Investment in the Construction Sector
BioCity announces the first patient dosed with its anti-TIM-3 mAb BC3402 in Combination with IMFINZI for the Treatment of Advanced Hepatocellular Carcinoma in a Phase Ib/II Trial
WUXI, China, Dec. 20, 2023 /PRNewswire/ — BioCity Biopharma today announced dosing of the first patient in a Phase Ib/II clinical trial of its anti-TIM-3 monoclonal antibody (mAb) BC3402 in combination with IMFINZI (durvalumab) for the treatment of advanced hepatocellular carcinoma (HCC) in China. The study is being conducted at Zhongshan Hospital with Prof. Jia… Continue reading BioCity announces the first patient dosed with its anti-TIM-3 mAb BC3402 in Combination with IMFINZI for the Treatment of Advanced Hepatocellular Carcinoma in a Phase Ib/II Trial